The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...
Selarsdi (ustekinumab-aekn), a biosimilar to Stelara (ustekinumab), is expanded to the indications to include treatment of Crohn disease ...
Medidata Solutions (Medidata), a leading provider of clinical trial solutions to the life sciences industry, that is part of Dassault Systèmes, has won two awards in the 2024 Pharmaceutical Technology ...
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback